These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11444725)

  • 1. Comparative tolerability of pharmacological treatments for patent ductus arteriosus.
    Hammerman C; Kaplan M
    Drug Saf; 2001; 24(7):537-51. PubMed ID: 11444725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
    El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
    Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003481. PubMed ID: 23633310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2010 Apr; (4):CD003481. PubMed ID: 20393936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.
    Johnston PG; Gillam-Krakauer M; Fuller MP; Reese J
    Clin Perinatol; 2012 Mar; 39(1):111-36. PubMed ID: 22341541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.
    Yadav S; Agarwal S; Maria A; Dudeja A; Dubey NK; Anand P; Yadav DK
    Pediatr Cardiol; 2014 Jun; 35(5):824-30. PubMed ID: 24435507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Sekar KC; Corff KE
    J Perinatol; 2008 May; 28 Suppl 1():S60-2. PubMed ID: 18446180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
    Heo MJ; Lee OS; Lim SC
    Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.
    Hu Y; Jin H; Jiang Y; Du J
    Pediatr Cardiol; 2018 Apr; 39(4):647-652. PubMed ID: 29468349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of therapeutics used in management of patent ductus arteriosus in preterm infants.
    Oncel MY; Erdeve O
    Curr Drug Saf; 2015; 10(2):106-12. PubMed ID: 25323589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus.
    Pacifici GM
    Curr Pediatr Rev; 2014; 10(3):216-37. PubMed ID: 25088343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.